Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them ...

On Thursday, in fact, the Centers for Disease Control and Prevention reported that obesity rates for children and teens ages 2-19 have reached an all-time high — hitting 21.1% between 2021 and 2021, ...

When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...

An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...

Physicians must deploy specific tools in specific ways at specific times — adding to the time-consuming treatment costs.

The FDA approved desmopressin acetate (Desmoda) oral solution for the management of central diabetes insipidus in adults and children, developer Eton Pharmaceuticals announced. The vasopressin analog ...

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

Orforglipron carried more side effects, however ...

A new nationwide analysis shows very early childhood Type 2 diabetes (T2D) is still uncommon but linked with where children ...

Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with ...

Hoffman Car Wash is partnering with Breakthrough T1D for a fundraiser to support diabetes research. According to Hoffman officials, for the first 10 days of March, 100 percent of every $5 Carbonite, ...